Favorable impact of a vegan diet with exercise on hemorheology: Implications for control of diabetic neuropathy

Medical Hypotheses

Volumn 58, Issue 6, 2002, Pages 476-486

  McCarty, Mark F ^a  

^a Pantox Laboratories   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN;

BLOOD FILTRATION; BLOOD RHEOLOGY; BLOOD VISCOSITY; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DIET; ERYTHROCYTE DEFORMABILITY; EXERCISE; GLUCOSE BLOOD LEVEL; HEMATOCRIT; HUMAN; PRIORITY JOURNAL; REVIEW; VASCULAR DISEASE;

EID: 0036618839     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1054/mehy.2001.1456     Document Type: Article

References (170)

1. Regression of diebetic neuropathy with total vegetarian (vegan) diet
2. Effect of near normoglycaemia for two years on progression of early diabetic retinopathy, nephropathy, and neuropathy: The Oslo study
3. Blood glucose control and diabetic microvascular complications: Long-term effects of near-normoglycaemia
4. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus
5. Changes in nerve conduction velocity after six weeks of glucoregulation with portable insulin infusion pumps
6. Peripheral nerve function and metabolic control in diabetes mellitus
7. Improvement of cardiovascular autonomic reflexes after amelioration of metabolic control in insulin-dependent diabetic subjects with severe autonomic neuropathy
8. Near normoglycaemia improved nerve conduction and vibration sensation in diabetic neuropathy
9. Effect of near normoglycaemia for two years on progression of early diabetic retinopathy, nephropathy, and neuropathy: The Oslo study
10. Increased nerve conduction in diabetics after a year of improved glucoregulation
11. Effects of continuous subcutaneous insulin infusion and intensified conventional therapy on peripheral and autonomic nerve dysfunction
12. Reversal of neuropathic and gastrointestinal complications related to diabetes mellitus in adolescents with improved metabolic control
13. Improvement of diabetic peripheral neuropathy with the portable insulin infusion pump
14. Continuous subcutaneous insulin infusion in the management of painful diabetic neuropathy
15. Peripheral nerve function in patients with painful diabetic neuropathy treated with continuous subcutaneous insulin infusion
16. Endoneurial blood flow and oxygen tension in the sciatic nerves of rats with experimental diabetic neuropathy
17. Prevention of some electrophysiologic and biochemical abnormalities with oxygen supplementation in experimental diabetic neuropathy
18. Sural nerve oxygen tension in diabetes
19. Experimental chronic hypoxic neuropathy: Relevance to diabetic neuropathy
20. Altered blood theology in the pathogenesis of diabetic and other neuropathies
21. Hypoxic neuropathy: Does hypoxia play a role in diabetic neuropathy? The 1988 Robert Wartenberg lecture
22. Hypoxic neuropathy: Relevance to human diabetic neuropathy
23. Nerve blood flow in early experimental diabetes in rats: Relation to conduction deficits
24. The aetiology of diabetic neuropathy: The combined roles of metabolic and vascular defects
25. 1)-adrenoceptor antagonist on diabetes-induced changes in peripheral nerve function, metabolism, and antioxidative defense
26. Effects of changes of blood pressure, respiratory acidosis and hypoxia on blood flow in the sciatic nerve of the rat
27. Red-cell aggregation and red-cell deformability in diabetes
28. Is hyperviscosity a treatable component of diabetic microcirculatory disease?
29. Blood viscosity in young male diabetics with and without retinopathy
30. Rheological properties of white blood cells are changed in diabetic patients with microvascular complications
31. Do theological variables play a role in diabetic peripheral neuropathy?
32. Leukocyte-capillary plugging and network resistance are increased in skeletal muscle of rats with streptozotocin-induced hyperglycemia
33. Circulating levels of interleukin-6, its soluble receptor and interleukin-6/interleukin-6 receptor complexes in patients with type 2 diabetes mellitus
34. Interleukin-6 as a central mediator of cardiovascular risk associated with chronic inflammation, smoking, diabetes, and visceral obesity: Down-regulation with essential fatty acids, ethanol and pentoxifylline
35. Leukocytes and the risk of ischemic diseases
36. Activated monocytes and granulocytes, capillary nonperfusion, and neovascularization in diabetic retinopathy
37. Leukocyte cytoskeletal structure determines capillary plugging and network resistance
38. The functions of circulatory polymorphonuclear leukocytes in diabetic patients with and without diabetic triopathy
39. Increased blood viscosity in diabetic proliferative retinopathy
40. Hemorheologic and hemostatic changes in long-standing insulin-dependent (type I) diabetic patients with peripheral and autonomic cardiovascular neuropathy
41. Rheological and microvascular parameters in diabetic peripheral neuropathy
42. Association of plasma fibrinogen level and blood pressure with diabetic retinopathy, and renal complications associated with proliferative diabetic retinopathy, in type 2 diabetes mellitus
43. Blood theology in vegetarians
44. Reduced plasma fibrinogen, serum peroxides, lipids, and apolipoproteins after a 3-week vegetarian diet
45. Changes in cardiovascular risk factors and hormones during a comprehensive residential three month kriya yoga training and vegetarian nutrition
46. The influence of a vegetarian diet on haemostatic risk factors for cardiovascular disease in Africans
47. Vegetarians and cardiovascular risk factors: Hemostasis, inflammatory markers and plasma homocysteine
48. Toward improved management of NIDDM: A randomized, controlled, pilot intervention using a lowfat, vegetarian diet
49. The origins of western obesity: A role for animal protein?
50. Controlled trial of fasting and one-year vegetarian diet in rheumatoid arthritis
51. Rheumatoid arthritis treated with vegetarian diets
52. Vegan regimen with reduced medication in the treatment of bronchial asthma
53. A fasting and vegetarian diet treatment trial on chronic inflammatory disorders
54. Dietary intake and biochemical, hematologic, and immune status of vegans compared with nonvegetarians
55. The insulin-like growth factor system in regulation of normal and malignant hematopoiesis
56. Growth hormone, growth factors and hematopoiesis
57. Vegan Proteins may reduce risk of cancer, obesity, and cardiovascular disease by promoting increased glucagon activity
58. Mortality from 'Western' cancers rose dramatically among African-Americans during the twentieth century: Are dietary animal products to blame?
59. Renal, metabolic, and hormonal responses to proteins of different origin in normotensive, nonproteinuric type I diabetic patients
60. Hormones and diet: Low insulin-like growth factor-I but normal bioavailable androgens in vegan men
61. Priming of human polymorphonuclear neutrophilic leukocytes by insulin-like growth factor I: Increased phagocytic capacity, complement receptor expression, degranulation, and oxidative burst
62. Demonstration of a relationship between white blood cell count, insulin resistance, and several risk factors for coronary heart disease in women
63. White blood cell count and insulin resistance in healthy nonsmoking men
64. The white blood cell count: Its relationship to plasma insulin and other cardiovascular risk factors in healthy male individuals
65. Insulin-like growth factor binding protein-1: Recent findings and new directions
66. Effect of low-fat, low-protein diet on blood viscosity factors
67. Placebo-controlled, double-blind trial of hemodilution in peripheral occlusive arterial disease
68. Dietary regulation of fibrinolytic factors
69. Relationship between hemorrheologic factors and insulin sensitivity in healthy young men
70. Reciprocal association between insulin sensitivity and the haematocrit in man
71. Hematocrit and hemoglobin are independently related to insulin resistance and compensatory hyperinsulinemia in healthy, non-obese men and women
72. Erythrocyte rheological changes in obese patients: Influence of hyperinsulinism
73. Insulin-driven erythropoiesis may underlie impairment of erythrocyte deformability in hyperinsulinaemic, hyperglycaemic ob/ob-mice
74. Role of diet and exercise in the management of hyperinsulinemia and associated atherosclerotic risk factors
75. Insulin induces transcription of target genes through the hypoxia-inducible factor HIF-1alpha/ARNT
76. Erythropoietin: Multiple physiological functions and regulation of biosynthesis
77. Increased erythropoiesis and elevated erythropoietin in infants born to diabetic mothers and in hyperinsulinemic rhesus fetuses
78. Neonatal polycythemia in infants of insulin-dependent diabetic mothers
79. Effects of prolonged hyperinsulinemia on erythropoiesis in fetal sheep
80. Fetal plasma erythropoietin in pregnancies complicated by maternal diabetes mellitus
81. Erythropoietin level in the blood of patients with diabetes mellitus type 2
82. Stimulation of human early and late erythropoietic progenitor cells by insulin: Evidence for different mechanisms
83. Increased response to subcutaneous erythropoietin on type I diabetic patients on CAPD: Is there a synergistic effect with insulin?
84. Insulin and insulin-like growth factor I support the proliferation of erythroid progenitor cells in bone marrow through the sharing of receptors
85. A new candidate for the regulation of erythropoiesis: Insulin-like growth factor I
86. Insulin-like growth factor-I augments erythropoietin-induced proliferation through enhanced tyrosine phosphorylation of STAT5
87. The role of insulin (INS) and insulin-like growth factor-I (IGF-I) in regulating human erythropoiesis: Studies in vitro under serum-free conditions - Comparison to other cytokines and growth factors
88. Insulin-like growth factor binding protein-1 is elevated in patients with polycythemia vera and stimulates erythroid burst formation in vitro
89. Phosphorylation of insulin-like growth factor binding proteins
90. High-carbohydrate, high-fiber diets for insulin-treated men with diabetes mellitus
91. Long-term use of a high-complex-carbohydrate, high-fiber, low-fat diet and exercise in the treatment of NIDDM patients
92. Insulin resistance and beta-cell dysfunction in aging: The importance of dietary carbohydrate
93. High-carbohydrate, high-fiber diets increase peripheral insulin sensitivity in healthy young and old adults
94. Elevated circulating free fatty acid levels impair endothelium-dependent vasodilation
95. Free fatty acid elevation impairs insulin-mediated vasodilation and nitric oxide production
96. Measurement of plasma glucose, free fatty acid, lactate, and insulin for 24 h in patients with NIDDM
97. Role of fatty acids in the pathogenesis of insulin resistance and NIDDM
98. Incorporation of beta cell redifferentiation therapy into a lipoprivic strategy for reversing type 2 diabetes
99. Vegetarian diet in mild hypertension
100. Is increased plasma viscosity a risk factor for high blood pressure?
101. Blood pressure in vegetarians
102. Vegetarian diet and blood pressure levels: Incidental or causal association?
103. Influence of regular physical activity on blood rheology
104. Blood rheology of former and active athletes
105. Hemostatic alterations with exercise conditioning in NIDDM
106. Haemorrheology and long term exercise
107. Leisure-time physical activity but not work-related physical activity is associated with decreased plasma viscosity: Results from a large population sample
108. The triphasic effects of exercise on blood rheology: Which relevance to physiology and pathophysiology?
109. Effect of daily muscular exercise in patients with intermittent claudication
110. Treatment of diabetic neuropathy with gamma-linolenic acid. Gamma-Linolenic Acid Multicenter Trial Group
111. Essential fatty acids in the management of impaired nerve function in diabetes
112. Long-term effects of eicosapentaenoic acid on diabetic peripheral neuropathy and serum lipids in patients with type II diabetes mellitus
113. The use of gamma-linolenic acid in diabetic neuropathy
114. Effectiveness of natural oils as sources of gamma-linolenic acid to correct peripheral nerve conduction velocity abnormalities in diabetic rats: Modulation by thromboxane A2 inhibition
115. Prevention of nerve conduction deficit in diabetic rats by polyunsaturated fatty acids
116. Alterations of Na,K-ATPase isoenzymes in the rat diabetic neuropathy: Protective effect of dietary supplementation with n-3 fatty acids
117. Fish oil supplementation prevents diabetes-induced nerve conduction velocity and neuroanatomical changes in rats
118. Fatty acid metabolism in health and disease: The role of delta-6-desaturase
119. Effects of pentoxifylline and prostaglandin El on cold blood perfusion studied by red blood cell deformability
120. Unsaturated fatty acids
121. Regulation of red blood cell filterability by Ca2+ influx and cAMP-mediated signaling pathways
122. Neutrophil function in peripheral arterial occlusive disease: The effects of prostaglandin El
123. Changes in blood lipids and fibrinogen with a note on safety in a long term study on the effects of n-3 fatty acids in subjects receiving fish oil supplements and followed for seven years
124. Blood fluidity and omega-3 fatty acids
125. The beneficial effects of omega-3 and omega-6 essential fatty acid supplementation on red blood cell rheology
126. The influence of dietary marine oil (Polepa) and evening primrose oil (Efamol) on prostaglandin production by the rat mesenteric vasculature
127. Clinical and experimental study on the long-term effect of dietary gamma-linolenic acid on plasma lipids, platelet aggregation, thromboxane formation, and prostacyclin production
128. Thromboxane (TX)A3 and prostaglandin (PG)I3 are formed in man after dietary eicosapentaenoic acid: Identification and quantification by capillary gas chromatography-electron impact mass spectrometry
129. The prostacyclin/thromboxane balance is favourably shifted in Greenland Eskimos
130. Vascular prostacyclin is increased in patients ingesting omega-3 polyunsaturated fatty acids before coronary artery bypass graft surgery
131. Treatment of diabetic polyneuropathy with the antioxidant thioctic acid (alpha-lipoic acid): A two year multicenter randomized double-blind placebo-controlled trial (ALADIN II). Alpha lipoic acid in diabetic neuropathy
132. Alpha-lipoic acid in the treatment of diabetic polyneuropathy in Germany: Current evidence from clinical trials
133. Lipoic acid improves nerve blood flow, reduces oxidative stress, and improves distal nerve conduction in experimental diabetic neuropathy
134. Effects of alpha-lipoic acid on neurovascular function in diabetic rats: Interaction with essential fatty acids
135. Effects of DL-alpha-lipoic acid on peripheral nerve conduction, blood flow, energy metabolism, and oxidative stress in experimental diabetic neuropathy
136. Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization
137. Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins
138. Regulation of vascular endothelial growth factor-dependent retinal neovascularization by insulin-like growth factor-1 receptor
139. Essential role of growth hormone in ischemia-induced retinal neovascularization
140. Why some cases of retinopathy worsen when diabetic control improves
141. Evidence that upregulation of serum IGF-1 concentration can trigger acceleration of diabetic retinopathy
142. Growth factor alterations in advanced diabetic retinopathy: A possible role of blood retina barrier breakdown
143. Systemic levels contribute significantly to increased intraocular IGF-I, IGF-II and IGF-BP3 [correction of IFG-BP3] in proliferative diabetic retinopathy
144. Renal, metabolic and hormonal responses to ingestion of animal and vegetable proteins
145. Comparison of a vegetable-based (soya) and an animal-based low-protein diet in predialysis chronic renal failure patients
146. Effect of varying quantity and quality of dietary protein intake in experimental renal disease in rats
147. Dietary composition and renal function in healthy subjects
148. Vegan supplemented diet in nephrotic syndrome
149. A low-nitrogen low-phosphorous vegan diet for patients with chronic renal failure
150. Effects of chronic and acute protein administration on renal function in patients with chronic renal insufficiency
151. Influence of diet and underlying renal disease on the rate of progression of chronic renal failure
152. Predominantly vegetarian diet in patients with incipient and early clinical diabetic nephropathy: Effects on albumin excretion rate and nutritional status
153. Dietary protein intake and the progressive nature of kidney disease: The role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease
154. Restriction of dietary protein and progression of renal failure in diabetic nephropathy
155. Insulin-like growth factor system and the kidney: Physiology, pathophysiology, and therapeutic implications
156. IGF-I inhibitors reduce compensatory hyperfiltration in the isolated rat kidney following unilateral nephrectomy
157. Studies of vegans: The fatty acid composition of plasma choline phosphoglycerides, erythrocytes, adipose tissue, and breast milk, and some indicators of susceptibility to ischemic heart disease in vegans and omnivore controls
158. Diet and serum lipids in vegan vegetarians: A model for risk reduction
159. Can lifestyle changes reverse coronary heart disease? The Lifestyle Heart Trial
160. Intensive lifestyle changes for reversal of coronary heart disease
161. Are predictors of coronary heart disease and lower-extremity arterial disease in type 1 diabetes the same? A prospective study
162. Beneficial effects of a high carbohydrate, high fiber diet on hyperglycemic diabetic men
163. High-carbohydrate, high-fiber diets for insulin-treated men with diabetes mellitus
164. Response of non-insulin-dependent diabetic patients to an intensive program of diet and exercise
165. Diet and exercise in the treatment of NIDDM: The need for early emphasis
166. Angina and vegan diet
167. The effects of dietary omega-3 polyunsaturated fatty acids on erythrocyte membrane phospholipids, erythrocyte deformability and blood viscosity in healthy volunteers